David Louis, MD

Dr. David Louis is a globally respected academic executive and diagnostic innovator currently serving as Chair of Pathology at Mass General Brigham, where he leads a 2,500-person team performing over 70 million laboratory tests annually with a $465 million operating budget. As the Benjamin Castleman Professor of Pathology at Harvard Medical School and former Pathologist-in-Chief at Massachusetts General Hospital, Dr. Louis has engineered major advancements in computational pathology, precision diagnostics, and enterprise integration, positioning pathology as a strategic growth lever within academic medicine.

A pioneering figure in molecular neuro-oncology, Dr. Louis has shaped diagnostic standards through his leadership of the WHO CNS tumor classifications and his roles in NIH advisory groups. He brings board-relevant experience in organizational transformation, scientific commercialization, and innovation governance. His founding of cIMPACT-NOW and ADAPTR highlights his capacity to build global coalitions and scale solutions for diverse systems, including resource-limited settings. With deep insight into healthcare operations, biomedical innovation, and global scientific frameworks, Dr. Louis offers strategic vision and operational rigor ideal for boards navigating transformation and growth.